Swedish clinical-stage vaccine company
Novavax ▸ Facts ▸ Comments ▸ News ▸ Videos
FDA fast tracks another possible COVID-19 vaccine
Credit: ABC Action News Duration: 01:43Published
You Might Like
India to get 100 million doses of Oxford COVID-19 vaccine by Dec, says Adar PoonawallaSII, which has tied up with five developers, has so far made 40 million doses of AstraZeneca vaccine in the past two months and aims to start manufacturing Novavax's contender soon.
India's Serum says produced 40 million doses of AstraZeneca Covid-19 vaccineSerum Institute of India, the world's largest vaccine producer, said on Thursday it has made 40 million doses of AstraZeneca's potential Covid-19 vaccine, and would soon begin making Novavax's rival..
Scott Morrison gives an update on Australia's COVID-19 vaccine progressTwo more COVID-19 vaccines have been secured for the Australian population under new agreements, bringing the Australian Government’s COVID-19 vaccine investment to more than $3.2 billion. Under the..
Novavax aims for 2 billion Covid-19 vaccine doses with expanded India deal
South Africa rolls out second coronavirus vaccine trialShares South Africa will launch clinical trials of a US-developed coronavirus vaccine with 2,900 volunteers this week, the second such study in the African country worst hit by the disease, lead..
Novavax becomes fifth COVID-19 vaccine developer to release promising early resultsThe candidate vaccine seems to have generated an immune reaction similar to those in people who have recovered from COVID-19, the data shows.
U.S. pumps $1.6 billion into Novavax’s COVID vaccine developmentNovavax Inc., one of the front-runners in the race to develop a COVID-19 vaccine, will receive $1.6 billion from the U.S. government, the biggest contribution yet from the Operation Warp Speed program...
Novavax gets U.S. defense funding for its COVID-19 vaccineNovavax Inc said on Thursday the U.S. Department of Defense (DoD) will give the late-stage biotech company up to $60 million to fund the manufacturing of its experimental COVID-19 vaccine.